Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Sleep Disorders

  Free Subscription

Articles published in Thorax

Retrieve available abstracts of 16 articles:
HTML format
Text format

Single Articles

    September 2018
  1. ADLER D, Janssens JP
    Estimating the probability of OSA in the spinal cord injury population: specific tools are still needed.
    Thorax. 2018;73:803-805.
    PubMed     Text format    

    May 2018
  2. PEPIN JL, Bailly S, Tamisier R
    Incorporating polysomnography into obstructive sleep apnoea phenotyping: moving towards personalised medicine for OSA.
    Thorax. 2018;73:409-411.
    PubMed     Text format    

  3. ZINCHUK AV, Jeon S, Koo BB, Yan X, et al
    Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea.
    Thorax. 2018;73:472-480.
    PubMed     Text format     Abstract available

    April 2018
  4. CORRAL J, Mogollon MV, Sanchez-Quiroga MA, Gomez de Terreros J, et al
    Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome.
    Thorax. 2018;73:361-368.
    PubMed     Text format     Abstract available

    February 2018
  5. BLOCH KE, Huber F, Furian M, Latshang TD, et al
    Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial.
    Thorax. 2018;73:174-184.
    PubMed     Text format     Abstract available

    January 2018
  6. MANDAL S, Suh ES, Harding R, Vaughan-France A, et al
    Nutrition and Exercise Rehabilitation in Obesity hypoventilation syndrome (NERO): a pilot randomised controlled trial.
    Thorax. 2018;73:62-69.
    PubMed     Text format     Abstract available

  7. BOREL JC, Borel AL, Piper AJ
    NERO: a pilot study but important step towards comprehensive management of obesity hypoventilation syndrome.
    Thorax. 2018;73:5-6.
    PubMed     Text format    

    December 2017
  8. GURALNICK AS, Balachandran JS, Szutenbach S, Adley K, et al
    Educational video to improve CPAP use in patients with obstructive sleep apnoea at risk for poor adherence: a randomised controlled trial.
    Thorax. 2017;72:1132-1139.
    PubMed     Text format     Abstract available

    August 2017
  9. GAISL T, Giunta C, Bratton DJ, Sutherland K, et al
    Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort study.
    Thorax. 2017;72:729-735.
    PubMed     Text format     Abstract available

  10. MARCUS CL, Keenan BT, Huang J, Yuan H, et al
    The obstructive sleep apnoea syndrome in adolescents.
    Thorax. 2017;72:720-728.
    PubMed     Text format     Abstract available

    June 2017
  11. SERINEL Y, Yee BJ, Grunstein RR, Wong KH, et al
    Chronotherapy for hypertension in obstructive sleep apnoea (CHOSA): a randomised, double-blind, placebo-controlled crossover trial.
    Thorax. 2017;72:550-558.
    PubMed     Text format     Abstract available

  12. TAMISIER R, Levy P, Pepin JL
    Do patients with obstructive sleep apnoea deserve new dedicated antihypertensive strategies?
    Thorax. 2017;72:495-497.
    PubMed     Text format    

    May 2017
  13. HOWARD ME, Piper AJ, Stevens B, Holland AE, et al
    A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome.
    Thorax. 2017;72:437-444.
    PubMed     Text format     Abstract available

  14. NODA JR, Masa JF, Mokhlesi B
    CPAP or non-invasive ventilation in obesity hypoventilation syndrome: does it matter which one you start with?
    Thorax. 2017;72:398-399.
    PubMed     Text format    

    March 2017
  15. HE BT, Lu G, Xiao SC, Chen R, et al
    Coexistence of OSA may compensate for sleep related reduction in neural respiratory drive in patients with COPD.
    Thorax. 2017;72:256-262.
    PubMed     Text format     Abstract available

  16. LAGHI F, Owens RL
    COPD+OSA: can two bad things be good for you?
    Thorax. 2017;72:204-205.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Sleep Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.